RecallDepth
Class II Ongoing

Nelarabine Injection, 250mg/50mL, (5mg/mL), packaged in: a) 50 mL Single-Dose Vial, NDC 70710-1839-1; b) 6 x 50 mL Single-Dose Vial, NDC 70710-1839-8, Rx only, Manufactured by Zydus Lifesciences Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc, Pennington, NJ

This recall is currently active, issued March 12, 2025. It was issued by Zydus Pharmaceuticals (Usa) Inc.

Company
Zydus Pharmaceuticals (Usa) Inc
Recall Initiated
February 13, 2025
Posted
March 12, 2025
Recall Number
D-0256-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,893 vials
Firm Location
Pennington, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution

USA Nationwide

Lot / Code Info

Lot: a) P300197, Exp. Aug-2025; P400113, Exp. May-26; b) P300169, Exp. Jun-2025; P400115, Exp. May-2026.

More recalls by Zydus Pharmaceuticals (Usa) Inc

View all recalls by this company →

Other recent Class II Drug recalls